![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Chapter
Modeling Cell Cycle Control and Cancer with pRB Tumor Suppressor
Cancer is a complex syndrome of diseases characterized by the increased abundance of cells that disrupts the normal tissue architecture within an organism. Defining one universal mechanism underlyi...
-
Article
Lymphomagenesis and female-specific lethality in p53-deficient mice occur independently of E2f1
-
Article
A dynamic switch in Rb+/− mediated neuroendocrine tumorigenesis
Rb+/− mice develop a complex spectrum of neuroendocrine tumors on a mixed genetic (129Sv × C57BL/6) background. To understand how the 129Sv and C57BL/6 contributions affect Rb+/− tumorigenesis, we serially backcr...
-
Chapter
Role of the RB Tumor Suppressor in Cancer
Apart from their coordinated inactivation by DNA tumor viral oncoproteins, the pRB and p53 tumor suppressor pathways were not known to be connected ten years ago. Within the last decade, our appreciation of ho...
-
Article
Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/−) mice
Mutation of the retinoblastoma tumour-suppressor gene (RB) leads to the deregulation of many proteins and transcription factors that interact with the retinoblastoma gene product (pRB), including members of th...